Voyager Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VYGR and other ETFs, options, and stocks.

About VYGR

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. 

CEO
Alfred W. Sandrock
CEOAlfred W. Sandrock
Employees
101
Employees101
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
101
Employees101

VYGR Key Statistics

Market cap
216.99M
Market cap216.99M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
87.75K
Average volume87.75K
High today
$5.73
High today$5.73
Low today
$5.50
Low today$5.50
Open price
$5.59
Open price$5.59
Volume
55.34K
Volume55.34K
52 Week high
$10.60
52 Week high$10.60
52 Week low
$2.54
52 Week low$2.54

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

VYGR Earnings

-$0.80
-$0.38
$0.03
$0.45
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 7, Pre-Market
ActualExpected Mar 7, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.